<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Maxillofac Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Maxillofac Surg</journal-id><journal-id journal-id-type="publisher-id">AMS</journal-id><journal-title-group><journal-title>Annals of Maxillofacial Surgery</journal-title></journal-title-group><issn pub-type="ppub">2231-0746</issn><issn pub-type="epub">2249-3816</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29264284</article-id><article-id pub-id-type="pmc">5717893</article-id><article-id pub-id-type="publisher-id">AMS-7-188</article-id><article-id pub-id-type="doi">10.4103/ams.ams_95_17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article - Evaluative Study</subject></subj-group></article-categories><title-group><article-title>Lugol Chromoscopy in the Follow-up of Head and Neck Carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>Cesar Augusto</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Durazzo</surname><given-names>Marcelo Doria</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>de Aquino Xavier</surname><given-names>Fl&#x000e1;via Cal&#x000f3;</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Gallottini</surname><given-names>Marina Helena Cury</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Louren&#x000e7;o</surname><given-names>S&#x000ed;lvia Vanessa</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Pinto J&#x000fa;nior</surname><given-names>D&#x000e9;cio dos Santos</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Magacho de Andrade</surname><given-names>Nat&#x000e1;lia Martins</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Miazaki</surname><given-names>Aline Paterno</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Dedivitis</surname><given-names>Rog&#x000e9;rio Aparecido</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Cernea</surname><given-names>Cl&#x000e1;udio Roberto</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Head and Neck Surgery, Hospital das Cl&#x000ed;nicas, University of S&#x000e3;o Paulo School of Medicine, S&#x000e3;o Paulo, Brazil</aff><aff id="aff2"><label>1</label>Department of Stomatology, University of S&#x000e3;o Paulo Dental School, S&#x000e3;o Paulo, Brazil</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Cesar Augusto Sim&#x000f5;es, Pra&#x000e7;a Amadeu Amaral, 47, Conjunto 41, S&#x000e3;o Paulo, Brasil. E-mail: <email xlink:href="simoesccp@terra.com.br">simoesccp@terra.com.br</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Dec</season><year>2017</year></pub-date><volume>7</volume><issue>2</issue><fpage>188</fpage><lpage>193</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2017 Annals of Maxillofacial Surgery</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction:</title><p>Lugol is helpful in identifying early second primary tumors (SPTs) during oroscopy and pharyngoscopy, but this technique has not been assessed during follow-up visits with these patients.</p></sec><sec id="st2"><title>Aim:</title><p>The aim of this study is to describe the use of Lugol (a low-cost method) to diagnose SPTs in the oral cavity and oropharynx.</p></sec><sec id="st3"><title>Methods:</title><p>Patients treated for squamous cell carcinoma of the head and neck were randomly assigned to two groups. Group A was examined with routine oroscopy and pharyngoscopy without Lugol, and Group B was examined with routine oroscopy and pharyngoscopy without stain and with Lugol. A total of 211 patients were included during 4 years.</p></sec><sec id="st4"><title>Results:</title><p>Six oral and oropharynx carcinomas were detected in Group A. Eighteen oral and oropharynx carcinomas were detected in Group B, twelve of which were not seen without chromoscopy but were detected with Lugol.</p></sec><sec id="st5"><title>Conclusion:</title><p>Lugol increases the detection of malignant lesions compared to routine examination alone.</p></sec></abstract><kwd-group><kwd>Coloring agents</kwd><kwd>low-cost diagnostic</kwd><kwd>Lugol</kwd><kwd>mouth neoplasms</kwd><kwd>prospective studies</kwd><kwd>squamous cell carcinoma</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Smokers and drinkers with squamous cell carcinoma of the head and neck have a high risk of developing a second primary tumor (SPT)[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>] based on the theory of field cancerization, proposed in 1946.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] According to the literature, the most frequent region of SPT development is the head and neck region.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref>]</p><p>Published guidelines suggest the following methods can be used during follow-up visits with patients with head and neck cancer for early detection of lesions in the mouth or oropharynx: routine visual inspection of the oral cavity, use of toluidine blue to detect neoplastic and preneoplastic lesions not visible to the naked eye, use of fluorescent dyes for diagnosis of injuries, and exfoliative cytology or biopsy of suspected cancerous areas.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>] Despite these guidelines, no studies have comprehensively assessed the advantages of each method of detecting SPT.[<xref rid="ref22" ref-type="bibr">22</xref>] Promising results with a method developed to detect the spectrum of light refraction of preneoplastic and neoplastic lesions have been shown;[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] however, this technique is not so employed in some centers due to the cost of equipment. Despite the prevalent diagnostic use of Lugol solution for the early detection of cervical cancer[<xref rid="ref26" ref-type="bibr">26</xref>] and esophageal cancers,[<xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref><xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref>] its ability to detect malignant tumors or premalignant lesions of the mucosa of the head and neck has not been thoroughly addressed. A recent study in which Lugol solution was used to detect SPT in the mouth and oropharynx suggested that this solution may potentially be used to identify malignant and premalignant lesions that are not detected during routine inspections;[<xref rid="ref36" ref-type="bibr">36</xref>] however, a more detailed and complete study is necessary to determine whether Lugol chromoscopy results in increased survival.</p><p>The aim of this study is to verify the impact of Lugol chromoscopy of the mouth and oropharynx on identification of SPTs during follow-up visits with patients with squamous cell carcinoma of the head and neck.</p></sec><sec sec-type="methods" id="sec1-2"><title>M<sc>ETHODS</sc></title><p>After obtaining Ethics Committee approval and informed consent of the patients involved, we evaluated 211 patients with primary cancer of the oral cavity, oropharynx, hypopharynx, and larynx during 4 years. These patients had histopathologically confirmed squamous cell carcinoma and were included in the study regardless of the stage of their cancer or the length and modality of treatment they had received. We separated the patients into two groups by drawing lots to assess whether Lugol increases the diagnosis of SPT. Patients were randomly assigned &#x02013; Group A and B.</p><p>The exclusion criteria were allergy to iodine, anatomical changes that would allow Lugol aspiration during the test, difficult to the examination such as trismus, presence of ulcerated tumors that could cause intense pain upon Lugol application, history of gastrointestinal bleeding within 30 days before the examination that predisposed patients to further episodes due to the irritant effects of Lugol in the esophageal mucosa, and who did not have a known diagnosis at the time of examination (the index tumor result of pathological analysis). Attempting these criteria 19 patients were excluded from the study.</p><p>In Group A, without the use of Lugol, lesions that could potentially form SPTs were detected by routine examination with artificial lighting.</p><p>In addition to the routine examination in Group B, we applied 2% Lugol solution (iodine - potassium iodide solution) in all mucosa of the mouth and oropharynx at an approximate dose of 3&#x02013;5 ml each one with the aid of a hand sprayer, without any previous preparation and enough to color mucosa [<xref ref-type="fig" rid="F1">Figure 1</xref>] and expose hypocolored lesions [Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>]. We reexamined 2 min after the spray application and always ask the patient to keep the solution in the oral cavity for about 1 min, chewing it, and them swallowing.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Aspect of the normal coloration in the oropharynx region extending up to the hypopharynx</p></caption><graphic xlink:href="AMS-7-188-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Example of examining the oral cavity of a patient from group B without the dye</p></caption><graphic xlink:href="AMS-7-188-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>The same patient of <xref ref-type="fig" rid="F2">figure 2</xref> with Lugol dye. The biopsy of this patient in the hypocored &#x000e1;rea near the center showed invasive carcinoma</p></caption><graphic xlink:href="AMS-7-188-g003"/></fig><p>In both groups, biopsies of regions classified as potentially cancerous or &#x0201c;suspect&#x0201d; were performed. In Group B, additional biopsies of hypopigmented (suspect) areas and normal (control) areas were performed.</p><p>In Group B, Lugol staining reached the optimal point for evaluation after one to 2 min of spraying and the mucosa remained colored for about 8 min. During this period, the appearance of the mucosa was assessed, lesions that were completely unstained or hypopigmented were treated with Lugol again to confirm the findings, and biopsies of hypopigmented and unstained areas [Figures <xref ref-type="fig" rid="F4">4</xref>-<xref ref-type="fig" rid="F7">7</xref>] were performed with a conventional Burke biopsy forceps. The biopsies were always conducted at the center of the hypopigmented area.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Hypocored floor lesion photograph whose pathological examination showed invasive carcinoma</p></caption><graphic xlink:href="AMS-7-188-g004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Aspect of hypocored lesion in the right oral tongue, whose pathological examination showed invasive carcinoma</p></caption><graphic xlink:href="AMS-7-188-g005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Photograph of lesion hypocored innerface commissure labial and whose pathology examination was low-risk dysplasia</p></caption><graphic xlink:href="AMS-7-188-g006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p>Photograph of hypocored lesion Jugal D whose pathological anatomical examination was low-risk dysplasia</p></caption><graphic xlink:href="AMS-7-188-g007"/></fig><p>We compared the gender, age, tumor-node-metastasis stage, and quantity and duration of alcohol and tobacco consumption of the patients in the two groups. Tobacco consumption was assessed using the Brinkman index.[<xref rid="ref37" ref-type="bibr">37</xref><xref rid="ref38" ref-type="bibr">38</xref>]</p><p>Diagnosis of dysplasia and malignant lesions was based on a classification suggested by Kujan <italic>et al</italic>., in 2006.[<xref rid="ref39" ref-type="bibr">39</xref><xref rid="ref40" ref-type="bibr">40</xref>] The biopsies were referred to for histopathological examination at the Department of Pathology of the Hospital das Cl&#x000ed;nicas, University of S&#x000e3;o Paulo School of Medicine, with descriptions of the original localization of the specimen and chromoscopy test characteristics. The slides were prepared using routine techniques and stained with H and E. Only one surgeon performed endoscopy and Lugol application. Two pathologists to avoid discrepancies in diagnostic criteria analyzed samples separately.</p></sec><sec sec-type="results" id="sec1-3"><title>R<sc>ESULTS</sc></title><p>Group A (patients examined without Lugol) was composed of 106 patients, whereas Group B (patients examined with Lugol) was composed of 105 patients. A total of nineteen patients were excluded from the study. Eight of those patients were excluded because had large ulcerated lesions in the mouth that could cause great discomfort during Lugol application, two were excluded because did not give a good visualization of the oral cavity because of trismus secondary to the treatment of the tumor index (scar retraction in the masticatory space), and nine patients who did not have a known diagnosis at the time of examination were also excluded from the study.</p><p>Patients in Group A were followed up for an average of 25.2 months and those in Group B were followed up for an average of 24.9 months.</p><p>The characteristics of Group A and B were compared statistically using the Q<sup>2</sup> test and both are comparable. Patients in Group A ranged in the age from 41 years to 94 years, with an average age of 61.73 &#x000b1; 10.98 years and a median age of 60.95 years. Patients in Group B ranged in the age from 40 years to 81 years, with an average age of 59.32 &#x000b1; 9.6 years and a median age of 58 years (<italic>P</italic> = 0.61). In Group A, 96 patients were men and ten were women. In Group B, 94 patients were men and 11 were women (<italic>P</italic> = 0.80).</p><p>Most patients in both groups had stage IV cancer. The most common sites of primary cancer were the mouth (11 patients in Group A and 19 patients in Group B) and the larynx (13 patients in Group A and 12 patients in Group B).</p><p>The rate of alcohol use was defined as the number of units of ethanol (1 IU of alcohol = 28 g) consumed per day multiplied by the number of years of consumption.[<xref rid="ref37" ref-type="bibr">37</xref>] The two groups had statistically similar rates of alcohol usage (<italic>P</italic> = 0.181). The Brinkman index (defined as the number of cigarettes smoked per day multiplied by the number of years of consumption) was used to quantify smoking exposure,[<xref rid="ref37" ref-type="bibr">37</xref><xref rid="ref38" ref-type="bibr">38</xref>] and this measure was also statistically similar in both groups (<italic>P</italic> = 0.118).</p><p>Fifty-five patients in Group B underwent biopsy of lesions that were hypopigmented after Lugol application. Of those biopsies, 11 were invasive carcinomas [Figures <xref ref-type="fig" rid="F8">8</xref> and <xref ref-type="fig" rid="F9">9</xref>], one was carcinoma <italic>in situ</italic> [Figures <xref ref-type="fig" rid="F10">10</xref> and <xref ref-type="fig" rid="F11">11</xref>], six were high-risk dysplasias, 27 were low-risk dysplasias, and 10 were normal tissues. No cancer was detected in pathological analysis of the random control biopsies, which showed 20 normal, 18 low-risk dysplasias, and 2 high-risk dysplasias.</p><fig id="F8" position="float"><label>Figure 8</label><caption><p>H and E of the biopsy of patient in Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref> with invasive carcinoma</p></caption><graphic xlink:href="AMS-7-188-g008"/></fig><fig id="F9" position="float"><label>Figure 9</label><caption><p>H and E of the biopsy of patient in Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref> with invasive carcinoma</p></caption><graphic xlink:href="AMS-7-188-g009"/></fig><fig id="F10" position="float"><label>Figure 10</label><caption><p>H and E of an hypocored area showed <italic>in situ</italic> carcinoma</p></caption><graphic xlink:href="AMS-7-188-g010"/></fig><fig id="F11" position="float"><label>Figure 11</label><caption><p>H and E of an hypocored area showed <italic>in situ</italic> carcinoma</p></caption><graphic xlink:href="AMS-7-188-g011"/></fig><p>Considering that hypopigmented areas contained both true-positive (cancerous) and false-positive (noncancerous) tissues and normal areas contained true-negative (noncancerous) and false-negative (cancerous) tissues, we determined that the sensitivity of this method was 1 (one), the specificity was 0.48, the accuracy was 0.55, the positive predictive value was 0.21, and the negative predictive value was 1 (one). All of these hypopigmented areas also noted to appear abnormal on traditional unstained endoscopy.</p><p>Within 6 months of follow-up, more SPTs were identified in patients in Group B than those in Group A; 12 patients in Group B (85.7%) and two patients in Group A (14.2%) had detectable injuries. We observed the emergence of six head and neck tumors in Group A between 3 and 37 months of follow-up. The average time at which these tumors were detected was 15.66 (&#x000b1;12.51) months after the study enrollment and the median time of detection was 12.5 months after study enrollment. In Group B, we detected 6 (six) tumors without Lugol and 12 tumors with Lugol. Of these tumors, the SPT were detected between 3 and 25 months after the first test. The average time at which these tumors were detected was 12.85 (&#x000b1;3.43) months after study enrollment, and the median time of detection was 8 (eight) months after the study enrollment.</p><p>Fourteen patients in Group A died and 10 (ten) of those deaths were related to the index tumor and no other tumor being found in these patients. Seventeen patients in Group B died and seven of those deaths were related to the index tumor, no other tumor being found in these patients. No deaths during the follow-up period were related to SPTs of the head and neck.</p><p>In Group A, the site most commonly affected by SPT was the mouth (5 cases, 25% of SPT), followed by the esophagus (3 cases, 15%). In Group B, the oropharynx and mouth were the most commonly affected sites; eight cases of SPT were detected at each site (34.78% of SPT).</p></sec><sec sec-type="discussion" id="sec1-4"><title>D<sc>ISCUSSION</sc></title><p>The increased number of SPT detected in patients in Group B can be attributed to the employment of Lugol, which allowed early diagnosis of ten tumors, similar as used in esophagus.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref>] Furthermore, the lesions that were hypopigmented with Lugol appeared normal on unstained visual inspection.</p><p>We have shown that Lugol chromoscopy is of great value in diagnosis.[<xref rid="ref41" ref-type="bibr">41</xref>] It allowed the examiner to detect hypopigmented areas that were shown to be early carcinomas in 10.4% of all patients who underwent biopsy. The sensitivity of oropharyngeal chromoscopy with Lugol is high (100%) and the specificity is moderate (48%). This level of specificity is not better than random chance (50%), and thus, this technique could lead to a significant number of unnecessary negative biopsies.</p><p>At the end of the study, we diagnosed six carcinomas in patients with head and neck SPT without Lugol; however, when we employed Lugol, 18 carcinomas in the mouth and oropharynx were identified, resulting in a relevant increase in the number of malignant diagnoses. Additional time, expense, and discomfort (causing several patients to be excluded from the study) are worth the additional detection of lesions that may be subclinical.[<xref rid="ref41" ref-type="bibr">41</xref>]</p><p>During the follow-up period, Lugol chromoscopy in the mouth and oropharynx did not impact the survival of the patients as it does in esophagus.[<xref rid="ref42" ref-type="bibr">42</xref>]</p><p>The group examined with Lugol had higher mortality than the group that underwent routine examination and no deaths were related to SPTs; however, it was a short period for conclusions. Additional studies could recommend how lead-time bias may affect these results. It is worth mentioning that longer follow-up may allow to detect further changes in mortality between the two groups as well as to detect additional SPT.</p><p>Tests for the presence or not of human papillomavirus infection were not done,[<xref rid="ref43" ref-type="bibr">43</xref><xref rid="ref44" ref-type="bibr">44</xref>] but this is a possible future study using Lugol for diagnosis. The low cost of this method may be a good alternative to the use of narrow-band image.[<xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref42" ref-type="bibr">42</xref><xref rid="ref43" ref-type="bibr">43</xref><xref rid="ref44" ref-type="bibr">44</xref><xref rid="ref45" ref-type="bibr">45</xref><xref rid="ref46" ref-type="bibr">46</xref>]</p><p>The value of this technique for subclinical detection of cancer is undeniable, so a potential application of this is to study molecular alterations in subclinical cancer form to understand better the mechanism of a clinical presentation form.[<xref rid="ref47" ref-type="bibr">47</xref>]</p><p>Other use of Lugol staining described may lead to a reduction in local recurrence, and improved survival is to assist excision of dysplasias and carcinomas <italic>in situ</italic> at mucosal resection margins of oral and oropharyngeal squamous cell.[<xref rid="ref48" ref-type="bibr">48</xref>] This early application of the dye at time of resection in our view may have results similar to ours without impact on the survival and cause larger resections with worse quality of life.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>C<sc>ONCLUSION</sc></title><p>The chromoscopy examination with Lugol's iodine is an important complement in the detection of primary tumors in the mouth and oropharynx, due to its high sensitivity. The prevalence of STP increased after the examination was held with Lugol's iodine.</p><sec id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-2" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AS</given-names></name><name><surname>Morar</surname><given-names>P</given-names></name><name><surname>Phillips</surname><given-names>DE</given-names></name><name><surname>Field</surname><given-names>JK</given-names></name><name><surname>Husband</surname><given-names>D</given-names></name><name><surname>Helliwell</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Second primary tumors in patients with head and neck squamous cell carcinoma</article-title><source>Cancer</source><year>1995</year><volume>75</volume><fpage>1343</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7882285</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>S</given-names></name><name><surname>Gates</surname><given-names>S</given-names></name></person-group><article-title>Multiple primary malignant tumors</article-title><source>J Cancer</source><year>1932</year><volume>16</volume><fpage>1358</fpage><lpage>414</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>TW</given-names></name><name><surname>Toohill</surname><given-names>RJ</given-names></name><name><surname>Lehman</surname><given-names>RH</given-names></name><name><surname>Duncavage</surname><given-names>JA</given-names></name><name><surname>Malin</surname><given-names>TC</given-names></name></person-group><article-title>Role of esophagoscopy in the evaluation of patients with head and neck carcinoma</article-title><source>Ann Otol Rhinol Laryngol</source><year>1983</year><volume>92</volume><fpage>369</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">6881842</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>LH</given-names></name><name><surname>Ozsahiin</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>GN</given-names></name><name><surname>Touboul</surname><given-names>E</given-names></name><name><surname>De Vataire</surname><given-names>F</given-names></name><name><surname>Andolenko</surname><given-names>P</given-names></name><etal/></person-group><article-title>Synchronous and metachrounous head and neck carcinomas</article-title><source>Ann Cancer</source><year>1994</year><volume>74</volume><fpage>1933</fpage><lpage>8</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riboli</surname><given-names>E</given-names></name><name><surname>Kaaks</surname><given-names>R</given-names></name><name><surname>Est&#x000e8;ve</surname><given-names>J</given-names></name></person-group><article-title>Nutrition and laryngeal cancer</article-title><source>Cancer Causes Control</source><year>1996</year><volume>7</volume><fpage>147</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">8850442</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>JR</given-names></name><name><surname>Boyle</surname><given-names>P</given-names></name></person-group><article-title>Nutrition and oral cancer</article-title><source>Cancer Causes Control</source><year>1996</year><volume>7</volume><fpage>101</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">8850439</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slaughter</surname><given-names>DP</given-names></name></person-group><article-title>Multicentric origin of intraoral carcinoma</article-title><source>Surgery</source><year>1946</year><volume>20</volume><fpage>133</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">20992244</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slaughter</surname><given-names>DP</given-names></name><name><surname>Southwick</surname><given-names>HW</given-names></name><name><surname>Smejkal</surname><given-names>W</given-names></name></person-group><article-title>Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin</article-title><source>Cancer</source><year>1953</year><volume>6</volume><fpage>963</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">13094644</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>WK</given-names></name><name><surname>Lippman</surname><given-names>SM</given-names></name><name><surname>Itri</surname><given-names>LM</given-names></name><name><surname>Karp</surname><given-names>DD</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Byers</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck</article-title><source>N Engl J Med</source><year>1990</year><volume>323</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">2202902</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000f3;n</surname><given-names>X</given-names></name><name><surname>Quer</surname><given-names>M</given-names></name><name><surname>Diez</surname><given-names>S</given-names></name><name><surname>Or&#x000fa;s</surname><given-names>C</given-names></name><name><surname>L&#x000f3;pez-Pousa</surname><given-names>A</given-names></name><name><surname>Burgu&#x000e9;s</surname><given-names>J</given-names></name><etal/></person-group><article-title>Second neoplasm in patients with head and neck cancer</article-title><source>Head Neck</source><year>1999</year><volume>21</volume><fpage>204</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">10208662</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herranz Gonz&#x000e1;lez-Botas</surname><given-names>J</given-names></name><name><surname>Sarandeses Garc&#x000ed;a</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;nez Vidal</surname><given-names>J</given-names></name><name><surname>V&#x000e1;zquez Barro</surname><given-names>C</given-names></name><name><surname>L&#x000f3;pez Amado</surname><given-names>M</given-names></name></person-group><article-title>Second primary tumors in patients with carcinoma of the head and neck</article-title><source>Acta Otorrinolaringol Esp</source><year>2000</year><volume>51</volume><fpage>149</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">10804117</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardiola</surname><given-names>E</given-names></name><name><surname>Pivot</surname><given-names>X</given-names></name><name><surname>Dassonville</surname><given-names>O</given-names></name><name><surname>Poissonnet</surname><given-names>G</given-names></name><name><surname>Marcy</surname><given-names>PY</given-names></name><name><surname>Otto</surname><given-names>J</given-names></name><etal/></person-group><article-title>Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?</article-title><source>Cancer</source><year>2004</year><volume>101</volume><fpage>2028</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15386394</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawata</surname><given-names>LT</given-names></name><name><surname>Biazolla</surname><given-names>ER</given-names></name><name><surname>Durazzo</surname><given-names>MD</given-names></name><name><surname>Ferraz</surname><given-names>AR</given-names></name></person-group><article-title>Second primary tumor in patients with squamous cell carcinoma in the mouth</article-title><source>Rev P&#x000f3; Grad</source><year>2006</year><volume>13</volume><fpage>20</fpage><lpage>4</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernea</surname><given-names>CR</given-names></name><name><surname>de Ara&#x000fa;jo Filho</surname><given-names>VJ</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>LG</given-names></name><name><surname>dos Santos</surname><given-names>LR</given-names></name><name><surname>Yano</surname><given-names>OJ</given-names></name><name><surname>Ferraz</surname><given-names>AR</given-names></name><etal/></person-group><article-title>[Second primary tumors: The role of the head and neck surgeon]</article-title><source>Rev Paul Med</source><year>1988</year><volume>106</volume><fpage>201</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3076974</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashberg</surname><given-names>A</given-names></name><name><surname>Samit</surname><given-names>AM</given-names></name></person-group><article-title>Early detection, diagnosis, and management of oral and oropharyngeal cancer</article-title><source>CA Cancer J Clin</source><year>1989</year><volume>39</volume><fpage>67</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">2495159</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>JB</given-names></name><name><surname>Oakley</surname><given-names>C</given-names></name><name><surname>Millner</surname><given-names>A</given-names></name><name><surname>Emerton</surname><given-names>S</given-names></name><name><surname>van der Meij</surname><given-names>E</given-names></name><name><surname>Le</surname><given-names>N</given-names></name><etal/></person-group><article-title>The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>1997</year><volume>83</volume><fpage>537</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9159812</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristofaro</surname><given-names>MG</given-names></name><name><surname>Cafaro</surname><given-names>D</given-names></name><name><surname>Lazzaro</surname><given-names>F</given-names></name><name><surname>Onofrio</surname><given-names>L</given-names></name><name><surname>Savino</surname><given-names>N</given-names></name><name><surname>Macchione</surname><given-names>B</given-names></name><etal/></person-group><article-title>Chromoendoscopy in the diagnosis of precancerous lesions of the esophagus. Our experience</article-title><source>Ann Ital Chir</source><year>2001</year><volume>72</volume><fpage>405</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11865692</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feaver</surname><given-names>GP</given-names></name><name><surname>Morrison</surname><given-names>T</given-names></name><name><surname>Humphris</surname><given-names>G</given-names></name></person-group><article-title>A study to determine the acceptability in patients and dentists of toluidine blue in screening for oral cancer</article-title><source>Prim Dent Care</source><year>1999</year><volume>6</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11819880</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashberg</surname><given-names>A</given-names></name></person-group><article-title>Tolonium (toluidine blue) rinse &#x02013; A screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV</article-title><source>JAMA</source><year>1981</year><volume>245</volume><fpage>2408</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">6164804</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Poh</surname><given-names>CF</given-names></name><name><surname>Laronde</surname><given-names>D</given-names></name><name><surname>Epstein</surname><given-names>JB</given-names></name><name><surname>Durham</surname><given-names>S</given-names></name><etal/></person-group><article-title>Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>8017</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16140975</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>PN</given-names></name><name><surname>Mickelson</surname><given-names>AR</given-names></name></person-group><article-title>Early diagnosis of oral cavity cancers</article-title><source>Otolaryngol Clin North Am</source><year>2006</year><volume>39</volume><fpage>295</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">16580912</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kujan</surname><given-names>O</given-names></name><name><surname>Glenny</surname><given-names>AM</given-names></name><name><surname>Duxbury</surname><given-names>AJ</given-names></name><name><surname>Thakker</surname><given-names>N</given-names></name><name><surname>Sloan</surname><given-names>P</given-names></name></person-group><article-title>Screening programmes for the early detection and prevention of oral cancer</article-title><source>Cochrane Database Syst Rev</source><year>2003</year><volume>4</volume><fpage>CD004150</fpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poh</surname><given-names>CF</given-names></name><name><surname>Ng</surname><given-names>SP</given-names></name><name><surname>Williams</surname><given-names>PM</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Laronde</surname><given-names>DM</given-names></name><name><surname>Lane</surname><given-names>P</given-names></name><etal/></person-group><article-title>Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device</article-title><source>Head Neck</source><year>2007</year><volume>29</volume><fpage>71</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16983693</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>PY</given-names></name><name><surname>Tsai</surname><given-names>TL</given-names></name><name><surname>Tai</surname><given-names>SK</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name></person-group><article-title>Effectiveness of narrow band imaging in patients with oral squamous cell carcinoma after treatment</article-title><source>Head Neck</source><year>2012</year><volume>34</volume><fpage>155</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">21322082</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piazza</surname><given-names>C</given-names></name><name><surname>Cocco</surname><given-names>D</given-names></name><name><surname>De Benedetto</surname><given-names>L</given-names></name><name><surname>Bon</surname><given-names>FD</given-names></name><name><surname>Nicolai</surname><given-names>P</given-names></name><name><surname>Peretti</surname><given-names>G</given-names></name><etal/></person-group><article-title>Role of narrow-band imaging and high-definition television in the surveillance of head and neck squamous cell cancer after chemo- and/or radiotherapy</article-title><source>Eur Arch Otorhinolaryngol</source><year>2010</year><volume>267</volume><fpage>1423</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20352239</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiller</surname><given-names>W</given-names></name></person-group><article-title>Early diagnosis of carcinoma of the cervix</article-title><source>Surg Gynecol Obstet</source><year>1933</year><volume>56</volume><fpage>210</fpage><lpage>22</lpage></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>K</given-names></name><name><surname>Kuwano</surname><given-names>H</given-names></name><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Sonoda</surname><given-names>K</given-names></name><name><surname>Sumiyoshi</surname><given-names>K</given-names></name><name><surname>Tsutsui</surname><given-names>S</given-names></name><etal/></person-group><article-title>What is the earliest malignant lesion in the esophagus?</article-title><source>Cancer</source><year>1996</year><volume>77</volume><fpage>1614</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8608552</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nothmann</surname><given-names>BJ</given-names></name><name><surname>Wright</surname><given-names>JR</given-names></name><name><surname>Schuster</surname><given-names>MM</given-names></name></person-group><article-title><italic>In vivo</italic> vital staining as an aid to identification of esophagogastric mucosal junction in man</article-title><source>Am J Dig Dis</source><year>1972</year><volume>17</volume><fpage>919</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">4116321</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>T</given-names></name><name><surname>Aruga</surname><given-names>H</given-names></name><name><surname>Inohara</surname><given-names>H</given-names></name><name><surname>Matsunaga</surname><given-names>T</given-names></name><name><surname>Shiozaki</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Endoscopic examination of the upper gastrointestinal tract for the presence of second primary cancers in head and neck cancer patients</article-title><source>Acta Otolaryngol Suppl</source><year>1993</year><volume>501</volume><fpage>103</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7680519</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitag</surname><given-names>CP</given-names></name><name><surname>Barros</surname><given-names>SG</given-names></name><name><surname>Kruel</surname><given-names>CD</given-names></name><name><surname>Putten</surname><given-names>AC</given-names></name><name><surname>Dietz</surname><given-names>J</given-names></name><name><surname>Gruber</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in Southern Brazil</article-title><source>Dis Esophagus</source><year>1999</year><volume>12</volume><fpage>191</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10631911</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamuro</surname><given-names>EM</given-names></name><name><surname>Cecconello</surname><given-names>I</given-names></name><name><surname>Iriya</surname><given-names>K</given-names></name><name><surname>Tomishigue</surname><given-names>T</given-names></name><name><surname>Oliveira</surname><given-names>MA</given-names></name><name><surname>Pinotti</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Lugol dye endoscopy for analysis of esophageal mucosa in achalasia</article-title><source>Hepatogastroenterology</source><year>1999</year><volume>46</volume><fpage>1687</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10430322</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>V</given-names></name><name><surname>Burtin</surname><given-names>P</given-names></name><name><surname>Bour</surname><given-names>B</given-names></name><name><surname>Blanchi</surname><given-names>A</given-names></name><name><surname>Oberti</surname><given-names>F</given-names></name><name><surname>Person</surname><given-names>B</given-names></name><etal/></person-group><article-title>Endoscopic detection of early esophageal cancer in a high risk population. Does the Lugol coloration improve the results of vide-endoscopic examination?</article-title><source>Gastrointest Endosc</source><year>1995</year><volume>41</volume><fpage>356</fpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Kitamura</surname><given-names>K</given-names></name><name><surname>Tsutsui</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>H</given-names></name><name><surname>Sugimachi</surname><given-names>K</given-names></name><etal/></person-group><article-title>How to detect early carcinoma of the esophagus</article-title><source>Hepatogastroenterology</source><year>1993</year><volume>40</volume><fpage>207</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">8325584</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>R</given-names></name></person-group><article-title>Esophageal cancer: Which stent, who places it, and where?</article-title><source>Endoscopy</source><year>1995</year><volume>27</volume><fpage>509</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">8565891</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>CA</given-names></name><name><surname>Durazzo</surname><given-names>MD</given-names></name><name><surname>Sampaio</surname><given-names>MA</given-names></name><name><surname>Kulcsar</surname><given-names>MA</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>LG</given-names></name><name><surname>Ferraz</surname><given-names>AR</given-names></name></person-group><article-title>Lugol chromoscopy for early diagnosis of second primary tumors in patients treated for carcinoma of the head and neck</article-title><source>Oral Oncol</source><year>2007</year><volume>2</volume><issue>Suppl</issue><fpage>195</fpage><lpage>6</lpage></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Launoy</surname><given-names>G</given-names></name><name><surname>Milan</surname><given-names>CH</given-names></name><name><surname>Faivre</surname><given-names>J</given-names></name><name><surname>Pienkowski</surname><given-names>P</given-names></name><name><surname>Milan</surname><given-names>CI</given-names></name><name><surname>Gignoux</surname><given-names>M</given-names></name><etal/></person-group><article-title>Alcohol, tobacco and oesophageal cancer: Effects of the duration of consumption, mean intake and current and former consumption</article-title><source>Br J Cancer</source><year>1997</year><volume>75</volume><fpage>1389</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">9155065</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chyou</surname><given-names>PH</given-names></name><name><surname>Nomura</surname><given-names>AM</given-names></name><name><surname>Stemmermann</surname><given-names>GN</given-names></name></person-group><article-title>Diet, alcohol, smoking and cancer of the upper aerodigestive tract: A prospective study among Hawaii Japanese men</article-title><source>Int J Cancer</source><year>1995</year><volume>60</volume><fpage>616</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">7860134</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elwood</surname><given-names>JM</given-names></name><name><surname>Pearson</surname><given-names>JC</given-names></name><name><surname>Skippen</surname><given-names>DH</given-names></name><name><surname>Jackson</surname><given-names>SM</given-names></name></person-group><article-title>Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx</article-title><source>Int J Cancer</source><year>1984</year><volume>34</volume><fpage>603</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">6500740</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kujan</surname><given-names>O</given-names></name><name><surname>Oliver</surname><given-names>RJ</given-names></name><name><surname>Khattab</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>SA</given-names></name><name><surname>Thakker</surname><given-names>N</given-names></name><name><surname>Sloan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation</article-title><source>Oral Oncol</source><year>2006</year><volume>42</volume><fpage>987</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16731030</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kujan</surname><given-names>O</given-names></name><name><surname>Khattab</surname><given-names>A</given-names></name><name><surname>Oliver</surname><given-names>RJ</given-names></name><name><surname>Roberts</surname><given-names>SA</given-names></name><name><surname>Thakker</surname><given-names>N</given-names></name><name><surname>Sloan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation</article-title><source>Oral Oncol</source><year>2007</year><volume>43</volume><fpage>224</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">16931119</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>FH</given-names></name><name><surname>Bernardo</surname><given-names>WM</given-names></name><name><surname>Ide</surname><given-names>E</given-names></name><name><surname>Rocha</surname><given-names>RS</given-names></name><name><surname>Aquino</surname><given-names>JC</given-names></name><name><surname>Minata</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: A systematic review and meta-analysis</article-title><source>BMC Cancer</source><year>2017</year><volume>17</volume><fpage>54</fpage><pub-id pub-id-type="pmid">28086818</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>EJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Ahn</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><name><surname>Jung</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: A prospective study</article-title><source>Dis Esophagus</source><year>2016</year><volume>29</volume><fpage>752</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26471351</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M</given-names></name></person-group><article-title>Relevance of HPV infections in head and neck cancers: Highlights of the 2016 ASCO annual meeting</article-title><source>HNO</source><year>2016</year><volume>64</volume><fpage>731</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">27601039</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pringle</surname><given-names>GA</given-names></name></person-group><article-title>The role of human papillomavirus in oral disease</article-title><source>Dent Clin North Am</source><year>2014</year><volume>58</volume><fpage>385</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">24655529</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>HY</given-names></name><name><surname>Liao</surname><given-names>CT</given-names></name><name><surname>Chiang</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>IH</given-names></name></person-group><article-title>Office-based narrow band imaging-guided flexible laryngoscopy tissue sampling: A cost-effectiveness analysis evaluating its impact on Taiwanese health insurance program</article-title><source>J Formos Med Assoc</source><year>2015</year><volume>114</volume><fpage>633</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23683388</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>JM</given-names></name><name><surname>Dockery</surname><given-names>P</given-names></name><name><surname>Wheatley</surname><given-names>AM</given-names></name><name><surname>Olivo</surname><given-names>M</given-names></name><name><surname>Keogh</surname><given-names>I</given-names></name><etal/></person-group><article-title>Point of care optical diagnostic technologies for the detection of oral and oropharyngeal squamous cell carcinoma</article-title><source>Surgeon</source><year>2015</year><volume>13</volume><fpage>321</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26148762</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muto</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Ohtsu</surname><given-names>A</given-names></name><name><surname>Ebihara</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Esumi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region</article-title><source>Carcinogenesis</source><year>2005</year><volume>26</volume><fpage>1008</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15718256</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaul</surname><given-names>JA</given-names></name><name><surname>Cymerman</surname><given-names>JA</given-names></name><name><surname>Hislop</surname><given-names>S</given-names></name><name><surname>McConkey</surname><given-names>C</given-names></name><name><surname>McMahon</surname><given-names>J</given-names></name><name><surname>Mehanna</surname><given-names>H</given-names></name><etal/></person-group><article-title>LIHNCS &#x02013; Lugol's iodine in head and neck cancer surgery: A multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma <italic>in situ</italic> at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: Study protocol for a randomised controlled trial</article-title><source>Trials</source><year>2013</year><volume>14</volume><fpage>310</fpage><pub-id pub-id-type="pmid">24063578</pub-id></element-citation></ref></ref-list></back></article>